Colloid Use in the Critically Ill
Authors: Mahlon M. Wilkes
Journal: Annals of Internal Medicine (2002)

Letters3 September 2002Colloid Use in the Critically IllMahlon M. Wilkes, PhD and Roberta J. Navickis, PhDMahlon M. Wilkes, PhDHygeia Associates; Grass Valley, CA 95949Search for more papers by this author and Roberta J. Navickis, PhDHygeia Associates; Grass Valley, CA 95949Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-137-5_Part_1-200209030-00024 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:In their editorial, Cook and Guyatt (1) contend that the results of our meta-analysis on albumin administration in acutely ill persons (2) are similar to those of an earlier meta-analysis by the Cochrane Injuries Group Albumin Reviewers (3). Cook and Guyatt feel that the apparent differences between this study and ours arise from the “spin” imparted to the findings by the authors of each study. This interpretation does not square with the data. We reported a pooled relative mortality risk of 1.11 (95% CI, 0.95 to 1.28), compared with 1.68 (CI, 1.26 to 2.23) in the earlier ...References1. Cook D, Guyatt G. Colloid use for fluid resuscitation: evidence and spin [Editorial]. Ann Intern Med. 2001;135:205-8. [PMID: 11487488] LinkGoogle Scholar2. Wilkes MM, Navickis RJ. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med. 2001;135:149-64. [PMID: 11487482] LinkGoogle Scholar3. . Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Cochrane Injuries Group Albumin Reviewers. BMJ. 1998;317:235-40. [PMID: 9677209] CrossrefMedlineGoogle Scholar4. Chernick MR. Bootstrap Methods: A Practitioner's Guide. New York: J Wiley; 1999. Google Scholar5. Klein R. What's happening to Britain's National Health Service? N Engl J Med. 2001;345:305-8. [PMID: 11474684] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Mahlon M. Wilkes, PhD; Roberta J. Navickis, PhDAffiliations: Hygeia Associates; Grass Valley, CA 95949 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoPatient Survival after Human Albumin Administration Mahlon M. Wilkes and Roberta J. Navickis Colloid Use for Fluid Resuscitation: Evidence and Spin Deborah Cook and Gordon Guyatt Colloid Use in the Critically Ill Deborah Cook Colloid Use in the Critically Ill Deborah Cook Metrics Cited byCase Scenario for Fluid Therapy in Septic ShockCase Scenario for Fluid Therapy in Septic ShockAlbumine : plus qu’un soluté de remplissage ?What Is the Best Approach to Fluid Management, Transfusion Therapy, and the End Points of Resuscitation in Trauma?American Burn Association Practice Guidelines Burn Shock ResuscitationPlasma expansion by polyethylene-glycol-modified albumin 3 September 2002Volume 137, Issue 5_Part_1Page: 370KeywordsAlbuminsConfidence intervalsDeath ratesHealth careMedical servicesMortalityRelative riskResearch designRisk managementStatistical data ePublished: 3 September 2002 Issue Published: 3 September 2002 Copyright & PermissionsCopyright © 2002 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...